Talaei-Khoei, Mojtaba
Riklin, Eric
Merker, Vanessa L.
Sheridan, Monica R.
Jordan, Justin T.
Plotkin, Scott R.
Vranceanu, Ana-Maria http://orcid.org/0000-0003-3994-6488
Funding for this research was provided by:
National Institutes of Health
U.S. Department of Defense
Children’s Tumor Foundation
Children’s Tumor Foundation
Children’s Tumor Foundation
Children’s Tumor Foundation
Children’s Tumor Foundation
Article History
Received: 16 May 2016
Accepted: 6 November 2016
First Online: 29 November 2016
Compliance with ethical standards
:
: Mojtaba Talaei-Khoei, Eric Riklin, Monica R. Sheridan and Justin T. Jordan report no disclosures. Vanessa L. Merker receives research support from the Program in Cancer Outcomes Research Training (NCIR25CA92203) and a Young Investigator Award from the Children’s Tumor Foundation. Scott R. Plotkin receives research support from the Children’s Tumor Foundation, NIH, and Department of Defense Neurofibromatosis Clinical Trials Consortium. Ana-Maria Vranceanu receives research support from the Children’s Tumor Foundation.